Locust Wood Capital Advisers’s GSK GSK Stock Holding History

Locust Wood Capital Advisers’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-557,412	Closed	-$28M	–	61
2018 Q3	$28M	Buy	557,412 +3,104	+0.6%	+$158K	1.94%	25
2018 Q2	$27.9M	Buy	554,308 +24,604	+5%	+$1.24M	2.22%	21
2018 Q1	$25.9M	Buy	+529,704	New	+$24.7M	2.64%	19
2015 Q2	–	Sell	-321,120	Closed	-$18.5M	–	45
2015 Q1	$18.5M	Buy	+321,120	New	+$18.4M	2.34%	19

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Locust Wood Capital Advisers's GSK Position: Q4 2018 in Review

Locust Wood Capital Advisers sold out of GSK (GSK) in Q4 2018, closing a stake of 557,412 shares — an estimated $28M sold.

Locust Wood Capital Advisers first reported a position in GSK in Q1 2015 and held it in 4 quarters. The position peaked at $28M in Q3 2018. 800 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

Locust Wood Capital Advisers reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
Locust Wood Capital Advisers sold 557,412 GSK shares in Q4 2018, an estimated $28M.
Locust Wood Capital Advisers first reported a position in GSK in Q1 2015 and held it in 4 quarters.
Locust Wood Capital Advisers's GSK position peaked at $28M in Q3 2018.
800 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Locust Wood Capital Advisers's 13F filing for Q4 2018, filed 1 Feb 2019.